E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/16/2006 in the Prospect News Biotech Daily.

New Issue: Adolor raises $125 million in follow-on at $25, discounted from $25.19 close

By Ronda Fears

Memphis, Feb. 16 - Adolor Corp. priced a follow-on offering of 5 million shares of common stock off the shelf at $25.00 per share, discounted from Wednesday's closing level of $25.19, via bookrunner Lehman Brothers Inc.

Exton, Pa.-based Adolor, which concentrates of pain medications, plans to use proceeds for general corporate purposes, which may include increasing its working capital, acquisitions, in-licensing of products or technologies and capital expenditures.

Issuer:Adolor Corp.
Issue:Follow-on stock offering
Gross proceeds:$125 million
Net proceeds:$117 million
Shares:5 million shares
Greenshoe:825,000 shares
Price:$25.00 per share
Bookrunner:Lehman Brothers Inc.
Co-managers:Pacific Growth Equities, LLC, Banc of America Securities, LLC and J.P. Morgan Securities Inc.
Pricing date:Feb. 15
Settlement date:Feb. 22
Stock symbol:Nasdaq: ADLR
Stock price:$25.19 at close Feb. 15

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.